Plain-English translation of NCT07300293 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This research looks at patients with type 2 diabetes who have been admitted to intensive care with a serious condition called lactic acidosis — when dangerous acid builds up in the blood. The study examines whether patients who were taking metformin before admission have different outcomes than those who were not taking the medication. Doctors want to understand whether this medication plays a bigger role in this complication than currently recognized.
Metformin is prescribed to millions of people with type 2 diabetes, but when patients get very sick and their kidneys fail, the medication can build up in their bodies and potentially contribute to lactic acidosis. Doctors aren't sure how much this medication affects survival rates, so this study aims to clarify whether the medication's role in this serious condition is being underestimated.
You likely qualify if…
You likely don't qualify if…
This is not an active treatment study — researchers will review your medical records from your hospital stay to see whether you were taking the diabetes medication before admission and how your condition progressed. Your involvement is purely observational, meaning researchers will gather information about your care and outcomes that already happened. No new visits or treatments are required.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
France